Sabra Healthcare REIT (NASDAQ:SBRA) Releases Quarterly Earnings Results

Sabra Healthcare REIT (NASDAQ:SBRA) issued its quarterly earnings results on Thursday. The real estate investment trust reported $0.11 EPS for the quarter, missing analysts’ consensus estimates of $0.37 by ($0.26), FiscalAI reports. The firm had revenue of $201.35 million for the quarter, compared to analysts’ expectations of $201.97 million. Sabra Healthcare REIT had a return on equity of 5.66% and a net margin of 20.09%.The business’s quarterly revenue was up 16.2% compared to the same quarter last year. During the same quarter last year, the firm earned $0.36 earnings per share. Sabra Healthcare REIT updated its FY 2026 guidance to 1.550-1.590 EPS.

Sabra Healthcare REIT Stock Down 0.4%

Shares of Sabra Healthcare REIT stock opened at $20.17 on Friday. Sabra Healthcare REIT has a twelve month low of $15.60 and a twelve month high of $20.54. The stock has a market cap of $5.03 billion, a price-to-earnings ratio of 31.52, a price-to-earnings-growth ratio of 1.43 and a beta of 0.67. The company has a current ratio of 5.19, a quick ratio of 5.19 and a debt-to-equity ratio of 0.92. The company has a fifty day moving average price of $19.04 and a 200 day moving average price of $18.76.

Sabra Healthcare REIT Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 27th. Investors of record on Friday, February 13th will be given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 5.9%. The ex-dividend date of this dividend is Friday, February 13th. Sabra Healthcare REIT’s dividend payout ratio is 166.67%.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on SBRA. UBS Group began coverage on Sabra Healthcare REIT in a research report on Tuesday, November 18th. They set a “neutral” rating and a $20.00 target price on the stock. Jefferies Financial Group reiterated a “buy” rating and set a $22.00 price objective on shares of Sabra Healthcare REIT in a report on Monday, December 15th. National Bank Financial set a $22.00 target price on shares of Sabra Healthcare REIT in a report on Friday, October 17th. Truist Financial upped their price target on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a “hold” rating in a research report on Tuesday, January 20th. Finally, Wall Street Zen lowered shares of Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a report on Friday, January 23rd. Four investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Sabra Healthcare REIT presently has an average rating of “Hold” and a consensus price target of $21.11.

Institutional Investors Weigh In On Sabra Healthcare REIT

Several institutional investors and hedge funds have recently modified their holdings of the stock. Balyasny Asset Management L.P. acquired a new position in Sabra Healthcare REIT in the 2nd quarter worth $49,955,000. Nuveen LLC lifted its stake in shares of Sabra Healthcare REIT by 28.6% in the fourth quarter. Nuveen LLC now owns 7,303,254 shares of the real estate investment trust’s stock worth $138,324,000 after acquiring an additional 1,625,072 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new position in Sabra Healthcare REIT in the fourth quarter valued at about $28,512,000. Qube Research & Technologies Ltd grew its stake in Sabra Healthcare REIT by 856.5% during the 2nd quarter. Qube Research & Technologies Ltd now owns 1,398,965 shares of the real estate investment trust’s stock valued at $25,797,000 after purchasing an additional 1,252,708 shares in the last quarter. Finally, Goldman Sachs Group Inc. grew its stake in Sabra Healthcare REIT by 65.9% during the 4th quarter. Goldman Sachs Group Inc. now owns 2,480,576 shares of the real estate investment trust’s stock valued at $46,982,000 after purchasing an additional 985,211 shares in the last quarter. Hedge funds and other institutional investors own 99.40% of the company’s stock.

Key Stories Impacting Sabra Healthcare REIT

Here are the key news stories impacting Sabra Healthcare REIT this week:

• Positive Sentiment: Company issued FY‑2026 EPS guidance of $1.550–$1.590, well above the consensus cited in releases (~$1.06), signaling management expects stronger earnings power next year. Sabra Reports Fourth Quarter 2025 Results; Introduces 2026 Guidance
• Positive Sentiment: Q4 operating metrics showed growth in key cash flow measures: FFO $0.36 and AFFO $0.37, and revenue grew ~16% year-over-year to ~$201M — supports the raised FY outlook if trends persist. Sabra Reports Fourth Quarter 2025 Results; Introduces 2026 Guidance
• Neutral Sentiment: Management will attend Citi’s Global Property CEO Conference (Mar 1–4), providing investors an opportunity for additional color on guidance assumptions and portfolio strategy. Investor meetings could reduce uncertainty if management addresses outstanding questions. Sabra Health Care REIT, Inc. to Attend Citi’s 2026 Global Property CEO Conference
• Negative Sentiment: GAAP net income per diluted share for Q4 was $0.11, missing analyst estimates (~$0.37) and down from $0.36 a year ago — a near-term earnings disappointment that likely pressured the stock. Sabra: Q4 Earnings Snapshot / Earnings Release
• Negative Sentiment: Analyst commentary (BMO) flagged soft FFO outlook and uncertainty tied to an RCA loan, supporting a Hold rating — these risks could keep investor sentiment cautious until resolution or clearer guidance detail. Sabra Healthcare REIT: Solid SHOP Momentum Offset by Soft FFO Outlook and RCA Loan Uncertainty

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.